News Medical on MSN16h
Inhaled antibody therapy shows promise for COVID-19 treatmentThe inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
Anti-C1q antibodies are highly prevalent among patients with IgG4-RD, particularly those with renal and skin manifestations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback